Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter
- 1 October 2002
- Vol. 60 (4) , 31-35
- https://doi.org/10.1016/s0090-4295(02)01693-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, AustriaUrology, 2001
- Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 ?g/L: Are they useful tools for early detection and screening of prostate cancer?International Journal of Cancer, 2001
- Consideration of Low PSA Cut-Off Levels to Optimize the Detection of Curable Prostate CancerEuropean Urology, 2001
- COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCERJournal of Urology, 2000
- Different Stability of Free and Complexed Prostate-Specific Antigen in Serum in Relation to Specimen Handling and Storage Conditionscclm, 2000
- Comparisons of the Various Combinations of Free, Complexed, and Total Prostate–Specific Antigen for the Detection of Prostate CancerEuropean Urology, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levelsThe Prostate, 1998
- In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samplesUrology, 1996
- Practice Trends in the Diagnosis and Management of Prostate Cancer in the United StatesJournal of Urology, 1995